Cargando…
The lantibiotic nukacin ISK-1 exists in an equilibrium between active and inactive lipid-II binding states
The lantibiotic nukacin ISK-1 exerts antimicrobial activity through binding to lipid II. Here, we perform NMR analyses of the structure of nukacin ISK-1 and the interaction with lipid II. Unexpectedly, nukacin ISK-1 exists in two structural states in aqueous solution, with an interconversion rate on...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156582/ https://www.ncbi.nlm.nih.gov/pubmed/30272026 http://dx.doi.org/10.1038/s42003-018-0150-3 |
_version_ | 1783358134497050624 |
---|---|
author | Fujinami, Daisuke -Mahin, Abdullah-Al Elsayed, Khaled M. Islam, Mohammad R. Nagao, Jun-ichi Roy, Urmi Momin, Sabrina Zendo, Takeshi Kohda, Daisuke Sonomoto, Kenji |
author_facet | Fujinami, Daisuke -Mahin, Abdullah-Al Elsayed, Khaled M. Islam, Mohammad R. Nagao, Jun-ichi Roy, Urmi Momin, Sabrina Zendo, Takeshi Kohda, Daisuke Sonomoto, Kenji |
author_sort | Fujinami, Daisuke |
collection | PubMed |
description | The lantibiotic nukacin ISK-1 exerts antimicrobial activity through binding to lipid II. Here, we perform NMR analyses of the structure of nukacin ISK-1 and the interaction with lipid II. Unexpectedly, nukacin ISK-1 exists in two structural states in aqueous solution, with an interconversion rate on a time scale of seconds. The two structures differ in the relative orientations of the two lanthionine rings, ring A and ring C. Chemical shift perturbation induced by the titration of lipid II reveals that only one state was capable of binding to lipid II. On the molecular surface of the active state, a multiple hydrogen-bonding site formed by amino acid residues in the ring A region is adjacent to a hydrophobic surface formed by residues in the ring C region, and we propose that these sites interact with the pyrophosphate moiety and the isoprene chain of the lipid II molecule, respectively. |
format | Online Article Text |
id | pubmed-6156582 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-61565822018-09-28 The lantibiotic nukacin ISK-1 exists in an equilibrium between active and inactive lipid-II binding states Fujinami, Daisuke -Mahin, Abdullah-Al Elsayed, Khaled M. Islam, Mohammad R. Nagao, Jun-ichi Roy, Urmi Momin, Sabrina Zendo, Takeshi Kohda, Daisuke Sonomoto, Kenji Commun Biol Article The lantibiotic nukacin ISK-1 exerts antimicrobial activity through binding to lipid II. Here, we perform NMR analyses of the structure of nukacin ISK-1 and the interaction with lipid II. Unexpectedly, nukacin ISK-1 exists in two structural states in aqueous solution, with an interconversion rate on a time scale of seconds. The two structures differ in the relative orientations of the two lanthionine rings, ring A and ring C. Chemical shift perturbation induced by the titration of lipid II reveals that only one state was capable of binding to lipid II. On the molecular surface of the active state, a multiple hydrogen-bonding site formed by amino acid residues in the ring A region is adjacent to a hydrophobic surface formed by residues in the ring C region, and we propose that these sites interact with the pyrophosphate moiety and the isoprene chain of the lipid II molecule, respectively. Nature Publishing Group UK 2018-09-25 /pmc/articles/PMC6156582/ /pubmed/30272026 http://dx.doi.org/10.1038/s42003-018-0150-3 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Fujinami, Daisuke -Mahin, Abdullah-Al Elsayed, Khaled M. Islam, Mohammad R. Nagao, Jun-ichi Roy, Urmi Momin, Sabrina Zendo, Takeshi Kohda, Daisuke Sonomoto, Kenji The lantibiotic nukacin ISK-1 exists in an equilibrium between active and inactive lipid-II binding states |
title | The lantibiotic nukacin ISK-1 exists in an equilibrium between active and inactive lipid-II binding states |
title_full | The lantibiotic nukacin ISK-1 exists in an equilibrium between active and inactive lipid-II binding states |
title_fullStr | The lantibiotic nukacin ISK-1 exists in an equilibrium between active and inactive lipid-II binding states |
title_full_unstemmed | The lantibiotic nukacin ISK-1 exists in an equilibrium between active and inactive lipid-II binding states |
title_short | The lantibiotic nukacin ISK-1 exists in an equilibrium between active and inactive lipid-II binding states |
title_sort | lantibiotic nukacin isk-1 exists in an equilibrium between active and inactive lipid-ii binding states |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156582/ https://www.ncbi.nlm.nih.gov/pubmed/30272026 http://dx.doi.org/10.1038/s42003-018-0150-3 |
work_keys_str_mv | AT fujinamidaisuke thelantibioticnukacinisk1existsinanequilibriumbetweenactiveandinactivelipidiibindingstates AT mahinabdullahal thelantibioticnukacinisk1existsinanequilibriumbetweenactiveandinactivelipidiibindingstates AT elsayedkhaledm thelantibioticnukacinisk1existsinanequilibriumbetweenactiveandinactivelipidiibindingstates AT islammohammadr thelantibioticnukacinisk1existsinanequilibriumbetweenactiveandinactivelipidiibindingstates AT nagaojunichi thelantibioticnukacinisk1existsinanequilibriumbetweenactiveandinactivelipidiibindingstates AT royurmi thelantibioticnukacinisk1existsinanequilibriumbetweenactiveandinactivelipidiibindingstates AT mominsabrina thelantibioticnukacinisk1existsinanequilibriumbetweenactiveandinactivelipidiibindingstates AT zendotakeshi thelantibioticnukacinisk1existsinanequilibriumbetweenactiveandinactivelipidiibindingstates AT kohdadaisuke thelantibioticnukacinisk1existsinanequilibriumbetweenactiveandinactivelipidiibindingstates AT sonomotokenji thelantibioticnukacinisk1existsinanequilibriumbetweenactiveandinactivelipidiibindingstates AT fujinamidaisuke lantibioticnukacinisk1existsinanequilibriumbetweenactiveandinactivelipidiibindingstates AT mahinabdullahal lantibioticnukacinisk1existsinanequilibriumbetweenactiveandinactivelipidiibindingstates AT elsayedkhaledm lantibioticnukacinisk1existsinanequilibriumbetweenactiveandinactivelipidiibindingstates AT islammohammadr lantibioticnukacinisk1existsinanequilibriumbetweenactiveandinactivelipidiibindingstates AT nagaojunichi lantibioticnukacinisk1existsinanequilibriumbetweenactiveandinactivelipidiibindingstates AT royurmi lantibioticnukacinisk1existsinanequilibriumbetweenactiveandinactivelipidiibindingstates AT mominsabrina lantibioticnukacinisk1existsinanequilibriumbetweenactiveandinactivelipidiibindingstates AT zendotakeshi lantibioticnukacinisk1existsinanequilibriumbetweenactiveandinactivelipidiibindingstates AT kohdadaisuke lantibioticnukacinisk1existsinanequilibriumbetweenactiveandinactivelipidiibindingstates AT sonomotokenji lantibioticnukacinisk1existsinanequilibriumbetweenactiveandinactivelipidiibindingstates |